Company intelligence / Profile preview
SEEK
- Ownership
- Private
- Development stage
- Other
Overview
The company has HIV and Influenza vaccines in clinical trials, with HIV-v vaccine in Phase 1b and a universal flu vaccine (Flu-v) in Phase 1b/II trials. The HIV vaccine generates both B-cell and T-cell responses against conserved regions of the virus.
- Therapeutic areas
- PulmonologyMetabolic DisordersImmunologyOtherInfectious Diseases
- Modalities
- Peptide vaccinesImmunotherapeutics
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on SEEK.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SEEK.